Upon administration, LPS activates microglia and astrocytes, which trigger pro-inflammatory modulators (IL-1β, IL-6, and TNF-α), causing the progression of neurological complications such as cognitive impairment [35,36]. Here, IL1B is linked to Cognitive impairment.